2007•Annals of OncologyOpen access

Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer

J-C. Eymard, Franck Priou, Alain Zannetti, Alain Ravaud, Daniel Lepille, P. Kerbrat, P. Sanchez Gomez, Bernard Paule, Dominique Genet, Patrice Herait, Evelyne Ecstein-Fraïsse, Florence Joly

Open full text 56 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 56 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Docetaxel, Estramustine, Medicine, Prostate cancer, Internal medicine, Oncology, Chemotherapy, Clinical endpoint